Skip to main content
Erschienen in: Endocrine Pathology 4/2017

10.10.2017

Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review

verfasst von: Francesca Ambrosi, Alberto Righi, Costantino Ricci, Lori A. Erickson, Ricardo V. Lloyd, Sofia Asioli

Erschienen in: Endocrine Pathology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Papillary thyroid carcinoma is the most common thyroid malignancy and it is usually associated with a good prognosis. However, recurrence, metastases, and cancer death may occur in 10 to 15% of patients with more aggressive types of papillary thyroid carcinoma, such as tall cell, columnar cell, solid variant, or the more recently described hobnail variant of papillary thyroid carcinoma. Papillary thyroid carcinoma with a prominent hobnail pattern is a moderately differentiated papillary thyroid carcinoma variant with aggressive clinical behavior and significant mortality. The hobnail variant of papillary thyroid carcinoma shows prominent hobnail features, which have also been referred to as micropapillary. The typical hobnail/micropapillary morphological features show loss of cellular polarity/cohesiveness and support an epithelial-mesenchymal transition as a possible mechanism of metastasis. BRAF p.V600E is the most common mutation in papillary thyroid carcinoma, including the hobnail variant; recent and continuing studies are focused on defining other molecular anomalies that may be useful for prognostic stratification and may provide therapeutic targets.
Literatur
1.
Zurück zum Zitat Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 2010 34:44–52, 2010.CrossRef Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 2010 34:44–52, 2010.CrossRef
3.
Zurück zum Zitat Ashraf K, Nosé V. Pathology of thyroid gland. In: Lloyd RV (Ed.) Endocrine Pathology, 1st edn. New York: Springer, pp. 181–235, 2010. Ashraf K, Nosé V. Pathology of thyroid gland. In: Lloyd RV (Ed.) Endocrine Pathology, 1st edn. New York: Springer, pp. 181–235, 2010.
4.
Zurück zum Zitat Lubitz CC, Sosa JA. The changing landscape of papillary thyroid cancer: epidemiology, management, and the implications for patients. Cancer 122: 3754–3759, 2016.CrossRefPubMed Lubitz CC, Sosa JA. The changing landscape of papillary thyroid cancer: epidemiology, management, and the implications for patients. Cancer 122: 3754–3759, 2016.CrossRefPubMed
5.
Zurück zum Zitat Asioli S, Erickson LA, Righi A, Lloyd RV. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol 44: 320–328, 2013.CrossRefPubMed Asioli S, Erickson LA, Righi A, Lloyd RV. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol 44: 320–328, 2013.CrossRefPubMed
6.
Zurück zum Zitat Asioli S, Maletta F, Pagni F, Pacchioni D, Vanzati A, Mariani S, et al. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review. Diagn Cytopathol 42:78–84, 2014.CrossRefPubMed Asioli S, Maletta F, Pagni F, Pacchioni D, Vanzati A, Mariani S, et al. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review. Diagn Cytopathol 42:78–84, 2014.CrossRefPubMed
7.
Zurück zum Zitat Nucera C. Evolution of resistance to thyroid cancer therapy. Aging (Albany NY) 8:1576–1577, 2016.CrossRef Nucera C. Evolution of resistance to thyroid cancer therapy. Aging (Albany NY) 8:1576–1577, 2016.CrossRef
8.
Zurück zum Zitat Kakudo K, Tang W, Ito Y, Mori I, Nakamura Y, Miyauchi A. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol 57:1041–1046, 2004.CrossRefPubMedPubMedCentral Kakudo K, Tang W, Ito Y, Mori I, Nakamura Y, Miyauchi A. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol 57:1041–1046, 2004.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Motosugi U, Murata S-I, Nagata K, Yasuda M, Shimizu M. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy? Thyroid 19:535–537, 2009.CrossRefPubMed Motosugi U, Murata S-I, Nagata K, Yasuda M, Shimizu M. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy? Thyroid 19:535–537, 2009.CrossRefPubMed
10.
Zurück zum Zitat Eloy C. Newly described thyroid tumours and variants. Diagn Histopathol 22:179–183, 2016.CrossRef Eloy C. Newly described thyroid tumours and variants. Diagn Histopathol 22:179–183, 2016.CrossRef
11.
Zurück zum Zitat Albores-Saavedra J. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases. Am J Surg Pathol 34: 913, 2010.CrossRefPubMed Albores-Saavedra J. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of 8 cases. Am J Surg Pathol 34: 913, 2010.CrossRefPubMed
12.
Zurück zum Zitat Rosai J, Albores-Saavedra J, Asioli S, Baloch ZW, Bogdanova T, Chen H, et al. Papillary thyroid carcinoma. In: Lloyd RV, Asa SL, Kloppel G, Rosai J. WHO classification of tumours of endocrine organs, 4th edition. Lyon: IARC Press, pp. 81–92, 2017. Rosai J, Albores-Saavedra J, Asioli S, Baloch ZW, Bogdanova T, Chen H, et al. Papillary thyroid carcinoma. In: Lloyd RV, Asa SL, Kloppel G, Rosai J. WHO classification of tumours of endocrine organs, 4th edition. Lyon: IARC Press, pp. 81–92, 2017.
13.
Zurück zum Zitat Lino-Silva LS, Domínguez-Malagón HR, Caro-Sánchez CH, Salcedo-Hernández RA. Thyroid gland papillary carcinomas with “micropapillary pattern,” a recently recognized poor prognostic finding: clinicopathologic and survival analysis of 7 cases. Hum Pathol 43:1596–1600, 2012.CrossRefPubMed Lino-Silva LS, Domínguez-Malagón HR, Caro-Sánchez CH, Salcedo-Hernández RA. Thyroid gland papillary carcinomas with “micropapillary pattern,” a recently recognized poor prognostic finding: clinicopathologic and survival analysis of 7 cases. Hum Pathol 43:1596–1600, 2012.CrossRefPubMed
14.
Zurück zum Zitat Lubitz CC, Economopoulos KP, Pawlak AC, Lynch K, Dias-Santagata D, Faquin WC, Sadow PM. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid 24:958–965, 2014.CrossRefPubMedPubMedCentral Lubitz CC, Economopoulos KP, Pawlak AC, Lynch K, Dias-Santagata D, Faquin WC, Sadow PM. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid 24:958–965, 2014.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Amacher AM, Goyal B, Lewis JS Jr, El-Mofty SK, Chernock RD. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation. Am J Surg Pathol 39:260–265, 2015.CrossRefPubMed Amacher AM, Goyal B, Lewis JS Jr, El-Mofty SK, Chernock RD. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation. Am J Surg Pathol 39:260–265, 2015.CrossRefPubMed
16.
Zurück zum Zitat Lee YS, Kim Y, Jeon S, Bae JS, Jung SL, Jung CK. Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review. Int J Clin Exp Pathol 8:7988–7997, 2015.PubMedPubMedCentral Lee YS, Kim Y, Jeon S, Bae JS, Jung SL, Jung CK. Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review. Int J Clin Exp Pathol 8:7988–7997, 2015.PubMedPubMedCentral
17.
Zurück zum Zitat Ieni A, Barresi V, Cardia R, Licata L, Di Bari F, Benvenga S, Tuccari G. The micropapillary/hobnail variant of papillary thyroid carcinoma: a review of series described in the literature compared to a series from one southern Italy pathology institution. Rev Endocr Metab Disord 17:521–527, 2016.CrossRefPubMed Ieni A, Barresi V, Cardia R, Licata L, Di Bari F, Benvenga S, Tuccari G. The micropapillary/hobnail variant of papillary thyroid carcinoma: a review of series described in the literature compared to a series from one southern Italy pathology institution. Rev Endocr Metab Disord 17:521–527, 2016.CrossRefPubMed
18.
Zurück zum Zitat Morandi L, Righi A, Maletta F, Rucci P, Pagni F, Gallo M, Rossi S, Caporali L, Sapino A, Lloyd RV, Asioli S. Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. Endocr Relat Cancer 24:107–117, 2017.CrossRefPubMed Morandi L, Righi A, Maletta F, Rucci P, Pagni F, Gallo M, Rossi S, Caporali L, Sapino A, Lloyd RV, Asioli S. Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. Endocr Relat Cancer 24:107–117, 2017.CrossRefPubMed
19.
Zurück zum Zitat Teng L, Deng W, Lu J, Zhang J, Ren X, Duan H, et al. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma. Oncotarget 28:22023–22033, 2017. Teng L, Deng W, Lu J, Zhang J, Ren X, Duan H, et al. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma. Oncotarget 28:22023–22033, 2017.
21.
Zurück zum Zitat Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1-133, 2016. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1-133, 2016.
22.
Zurück zum Zitat Cassol CA, Asa SL. Molecular pathology of thyroid cancer. Diagn Histopathol 17:124–139, 2011.CrossRef Cassol CA, Asa SL. Molecular pathology of thyroid cancer. Diagn Histopathol 17:124–139, 2011.CrossRef
23.
Zurück zum Zitat Perros P. Report of the thyroid cancer guidelines update group. In: British Thyroid Association & Royal College of Physicians (Ed.) Guidelines for the Management of Thyroid Cancer, 2nd edn. London: Royal College of Physicians, pp. 1–92, 2007. Perros P. Report of the thyroid cancer guidelines update group. In: British Thyroid Association & Royal College of Physicians (Ed.) Guidelines for the Management of Thyroid Cancer, 2nd edn. London: Royal College of Physicians, pp. 1–92, 2007.
24.
Zurück zum Zitat Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132:658–665, 2009.CrossRefPubMed Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132:658–665, 2009.CrossRefPubMed
25.
Zurück zum Zitat Bellevicine C, Cozzolino I, Malapelle U, Zeppa P, Troncone G. Cytological and molecular features of papillary thyroid carcinoma with prominent hobnail features: a case report. Acta Cytol 56:560–564, 2012.CrossRefPubMed Bellevicine C, Cozzolino I, Malapelle U, Zeppa P, Troncone G. Cytological and molecular features of papillary thyroid carcinoma with prominent hobnail features: a case report. Acta Cytol 56:560–564, 2012.CrossRefPubMed
26.
Zurück zum Zitat Lee SH, Jung CK, Bae JS, Jung SL, Choi YJ, Kang CS. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma. Diagnostic Cytopathol 42:11–17, 2014.CrossRef Lee SH, Jung CK, Bae JS, Jung SL, Choi YJ, Kang CS. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma. Diagnostic Cytopathol 42:11–17, 2014.CrossRef
27.
Zurück zum Zitat Lloyd RV, Erickson LA, Asioli S. In response. Am J Surg Pathol 34: 914, 2010.CrossRef Lloyd RV, Erickson LA, Asioli S. In response. Am J Surg Pathol 34: 914, 2010.CrossRef
28.
Zurück zum Zitat Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244–285, 2011.CrossRefPubMedPubMedCentral Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244–285, 2011.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Nassar H, Pansare V, Zhang H, Che M, Sakr W, Ali-Fehmi R, Grignon D, et al. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol 17:1045–1050, 2004.CrossRefPubMed Nassar H, Pansare V, Zhang H, Che M, Sakr W, Ali-Fehmi R, Grignon D, et al. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol 17:1045–1050, 2004.CrossRefPubMed
30.
Zurück zum Zitat Romei C, Elisei R. RET/PTC translocations and clinico-pathological features in human papillary thyroid carcinoma. Front Endocrinol (Lausanne). 11;3:54, 2012. Romei C, Elisei R. RET/PTC translocations and clinico-pathological features in human papillary thyroid carcinoma. Front Endocrinol (Lausanne). 11;3:54, 2012.
31.
Zurück zum Zitat Abubaker J, Jehan Z, Bavi P, Sultana M, Al-Harbi S, Ibrahim M, Al-Nuaim A, et al. Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population. J Clin Endocrinol Metab 93:611–618, 2008.CrossRefPubMed Abubaker J, Jehan Z, Bavi P, Sultana M, Al-Harbi S, Ibrahim M, Al-Nuaim A, et al. Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population. J Clin Endocrinol Metab 93:611–618, 2008.CrossRefPubMed
32.
Zurück zum Zitat Lui WO, Zeng L, Rehrmann V, Deshpande S, Tretiakova M, Kaplan EL, Leibiger I, et al. CREB3L2-PPARγ fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis. Cancer Res 68:7156–7164, 2008.CrossRefPubMed Lui WO, Zeng L, Rehrmann V, Deshpande S, Tretiakova M, Kaplan EL, Leibiger I, et al. CREB3L2-PPARγ fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis. Cancer Res 68:7156–7164, 2008.CrossRefPubMed
33.
Zurück zum Zitat Santarpia L, El-Naggar AK, Cote GJ, Myers JN, Sherman SI.. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. J Clin Endocrinol Metab 93:278–284, 2008.CrossRefPubMed Santarpia L, El-Naggar AK, Cote GJ, Myers JN, Sherman SI.. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. J Clin Endocrinol Metab 93:278–284, 2008.CrossRefPubMed
34.
Zurück zum Zitat Viola D, Valerio L, Molinaro E, Agate L, Bottici V, Biagini A, Lorusso L, et al. 2016. Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocr Relat Cancer, 23:R185–R205CrossRefPubMed Viola D, Valerio L, Molinaro E, Agate L, Bottici V, Biagini A, Lorusso L, et al. 2016. Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocr Relat Cancer, 23:R185–R205CrossRefPubMed
35.
Zurück zum Zitat Ciampi R, Nikiforov YE. Alterations of the BRAF gene in thyroid tumors. Endocr Pathol 16:163–171, 2005.CrossRefPubMed Ciampi R, Nikiforov YE. Alterations of the BRAF gene in thyroid tumors. Endocr Pathol 16:163–171, 2005.CrossRefPubMed
36.
Zurück zum Zitat Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309:1493–1501, 2013.CrossRefPubMedPubMedCentral Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309:1493–1501, 2013.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab 99: E754–E765, 2014.CrossRefPubMedPubMedCentral Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J Clin Endocrinol Metab 99: E754–E765, 2014.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E, et al. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition. J Clin Pathol 64:325–329, 2011.CrossRefPubMed Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E, et al. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition. J Clin Pathol 64:325–329, 2011.CrossRefPubMed
39.
Zurück zum Zitat Hardin H, Guo Z, Shan W, Montemayor-Garcia C, Asioli S, Yu X-M, Harrison AD, et al. The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression. Am J Pathol 184:2342–2354, 2014.CrossRefPubMedPubMedCentral Hardin H, Guo Z, Shan W, Montemayor-Garcia C, Asioli S, Yu X-M, Harrison AD, et al. The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression. Am J Pathol 184:2342–2354, 2014.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Modern Pathol 23:1269–1278, 2010.CrossRef Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Modern Pathol 23:1269–1278, 2010.CrossRef
Metadaten
Titel
Hobnail Variant of Papillary Thyroid Carcinoma: a Literature Review
verfasst von
Francesca Ambrosi
Alberto Righi
Costantino Ricci
Lori A. Erickson
Ricardo V. Lloyd
Sofia Asioli
Publikationsdatum
10.10.2017
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 4/2017
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-017-9502-7

Weitere Artikel der Ausgabe 4/2017

Endocrine Pathology 4/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie